Literature DB >> 2566500

Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.

M Morelli1, S Fenu, L Garau, G Di Chiara.   

Abstract

The D-1 receptor agonist, SKF 38393 (2 mg/kg s.c.), failed to elicit contralateral turning when administered to drug-naive rats 17 days after unilateral 6-hydroxydopamine (6-OHDA) lesioning of the medial forebrain bundle, while it elicited intense contralateral turning 90 days post-lesioning. On the other hand the D-1/D-2 receptor agonist, apomorphine (0.1 mg/kg s.c.), induced contralateral turning in drug-naive rats lesioned 14 days earlier and made the administration of SKF 38393 (2 mg/kg s.c.) 3 days later effective to evoke contralateral turning ('priming'). The effectiveness of apomorphine as a primer of SKF 38393-induced turning depended critically on the interval between the administration of the two agonists. Effectiveness was minimal after 3 h and increased after 6-12 h, peaked at 72 h and was reduced after 10 days. The D-2 receptor agonist, LY 171555 (0.2 mg/kg s.c.), was also effective as a primer of SKF 38393-induced contralateral turning and this effect also was dependent upon the interval between priming and SKF 38393 administration. Moreover, priming was dependent on the dose of drug used as primer and on the dose of SKF 38393 used as a challenge. In contrast to SKF 38393, priming was unable to make effective a dose of LY 171555 that was ineffective in drug-naive rats, suggesting that LY 171555 affects D-1-dependent turning to a greater extent than D-2-dependent turning. The results indicate that the priming phenomenon is rather strictly time- and dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566500     DOI: 10.1016/0014-2999(89)90296-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  The D1 receptor-mediated effects of the ergoline derivative LEK-8829 in rats with unilateral 6-hydroxydopamine lesions.

Authors:  M Zivin; L Sprah; D Sket
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Evaluation of the integrity of the dopamine system in a rodent model of Parkinson's disease: small animal positron emission tomography compared to behavioral assessment and autoradiography.

Authors:  Elissa M Strome; Ivan L Cepeda; Vesna Sossi; Doris J Doudet
Journal:  Mol Imaging Biol       Date:  2006 Sep-Oct       Impact factor: 3.488

3.  Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.

Authors:  M Morelli; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.

Authors:  M Y Wong; A Borgkvist; S J Choi; E V Mosharov; N S Bamford; D Sulzer
Journal:  Neuroscience       Date:  2015-01-28       Impact factor: 3.590

5.  Loss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.

Authors:  Anders Borgkvist; Elizabeth M Avegno; Minerva Y Wong; Mazen A Kheirbek; Mark S Sonders; Rene Hen; David Sulzer
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

6.  Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.

Authors:  Vasily Vorobyov; Frank Sengpiel
Journal:  Exp Brain Res       Date:  2008-08-06       Impact factor: 1.972

7.  Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

Review 8.  Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?

Authors:  Agnès Nadjar; Charles R Gerfen; Erwan Bezard
Journal:  Prog Neurobiol       Date:  2008-09-30       Impact factor: 11.685

9.  A complex program of striatal gene expression induced by dopaminergic stimulation.

Authors:  J D Berke; R F Paletzki; G J Aronson; S E Hyman; C R Gerfen
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

10.  Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.

Authors:  J Fornaguera; J P Huston; R J Carey; R K Schwarting
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.